Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Restoring social participation after chronic stroke with strategy training plus acceptance and commitment therapy

Official title: Rehabilitation Strategies for Social Participation in Chronic Stroke Survivors

Run by University of Pittsburgh · NCT06758505 · Data updated 2026-11-12

This program will test whether adding acceptance and commitment therapy to strategy training helps adults living with chronic stroke reconnect with social activities.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment54 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedSeptember 29, 2025
Main results expectedJune 2027
Study endsSeptember 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT06758505 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) living in the community at least six months after a stroke who report reduced social participation (Activity Card Sort <80% of pre-stroke activities) and can give informed consent are ideal candidates.

Probably not a fit

People with progressive neurological disorders, severe aphasia that prevents participation, those currently in active stroke rehabilitation or with untreated major depression, or those with bipolar/psychotic disorders may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, home-based intervention assigns community-dwelling adults at least six months after stroke to 10 sessions of either standard strategy training (START) or strategy training embedded with Acceptance and Commitment Therapy principles (ACES). Social participation and psychological flexibility are measured at baseline, immediately after the intervention, and one month later to compare changes between groups. The primary aim is to see if ACES produces clinically meaningful improvements (Cohen's d ≥ 0.2) in social participation compared with START. Key exclusions include progressive neurological disease, severe aphasia, active stroke rehabilitation or untreated major depression, and bipolar or psychotic disorders.

Why it matters

Potential benefit: If successful, the combined ACES approach could help people with chronic stroke increase social participation and reduce psychological barriers to community life.

How similar studies have gone: Strategy training has prior evidence for improving activity engagement after stroke and ACT has improved psychological flexibility in other populations, but combining them to improve social participation after chronic stroke is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. primary diagnosis of chronic stroke, ≥6 months post onset,
2. ≥18 years old,
3. community-dwelling (i.e., living in a residential setting in the community),
4. restrictions in social participation, indicated by Activity Card Sort (\<80% of pre-stroke activities)

Exclusion Criteria:

1. progressive neurological diagnosis (e.g., dementia, Parkinson's disease, multiple sclerosis, or brain tumor) reported by participants or proxy,
2. inability to provide written informed consent,
3. severe aphasia (score 0 or 1 on the Boston Diagnostic Aphasia Examination 3rd Edition Severity Rating Scale),
4. currently undergoing stroke rehabilitation or mental health intervention (but participation in maintenance sessions, self-help groups, or couples therapy is permitted),
5. major depressive disorder, indicated by PRIME-MD, unless undergoing treatment for at least 4 weeks and are released to participate by their physician or counselor
6. bipolar or psychotic disorder, indicated by PRIME-MD, or
7. substance use disorder within 3 months, indicated by Mini-International Neuropsychiatric Interview

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Minmei Shih, PhD — University of Pittsburgh
  • Study coordinator: Minmei Shih, PhD
  • Email: mis235@pitt.edu
  • Phone: 412-383-4551

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.